InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by EPSTEIN ROBERT S, Director. Director active across 3 companies, notably Veracyte, INC.. In total, 11 filings have been recorded. The latest transaction was disclosed on 1 October 2025 — Levée d'options. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations11 total
US$67,66610,000 shares@ US$6.76660.0022% mcap100.0% of flow
Common Stock
SEC:0001252004-25-000005·
€67,66610,000 shares@ €6.76660.0022% mcap50.0% of flow
Common Stock
SEC:0001252004-25-000005:0·
014,731 shares0
Common Stock
SEC:0001384101-22-000098:0·
08,650 shares0
Common Stock
SEC:0001209191-22-036345:0·
01,232 shares0
Common Stock
SEC:0001127602-22-015920:0·
08,720 shares0
Common Stock
SEC:0001384101-21-000114·
08,720 shares0
Common Stock
SEC:0001384101-21-000114:0·
02,681 shares0
Common Stock
SEC:0000899243-21-022085·
02,681 shares0
Common Stock
SEC:0000899243-21-022085:0·
€124,809385 shares@ €324.17910.0006% mcap100.0% of flow
Common Stock
SEC:0001127602-21-018202·
€124,809385 shares@ €324.17910.0006% mcap50.0% of flow
Common Stock
SEC:0001127602-21-018202:0·
11 of 11 declarations
About EPSTEIN ROBERT S
Robert S. Epstein is a Board Member at Veracyte, Inc., Illumina, Inc., and Fate Therapeutics Inc. He brings expertise in corporate governance and strategy. His role involves overseeing operations and contributing to strategic decision-making within these companies. Through his experience, he plays a key role in shaping governance policies and practices, ensuring compliance and organizational effectiveness.
